Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia

NCT04522739 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04522739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04522739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
September 6, 2022
Completion date
September 23, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment